Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory Lymphoma

NCT05607498

Conditions: Advanced/Metastatic Solid Tumors, Disease Attributes, Hemic and Lymphatic Diseases, +11 more
Locations: Peninsula and South Eastern Haematology and Oncology Group Frankston, Victoria, Australia

One Clinical Research Nedlands, Western Australia, Australia

Hunan Cancer Hospital Changsha, Hunan, China

Affiliated Hospital of Hebei University Baoding, China

View Trial Details

Recruiting

Comparative Diagnostic Yield of Endobronchial Cryo Biopsy vs Forceps Biopsy in Patients With Suspected Sarcoidosis

NCT06853834

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +10 more
Locations: Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow, Uttar Pradesh, India

View Trial Details

Recruiting

A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)

NCT06170489

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Comparison of the Effects of Yoga and Conventional Physiotherapy Programs in Sarcoidosis

NCT06848608

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +6 more
Locations: Süreyyapaşa Chest Diseases and Chest Surgery Training and Research Hospital Istanbul, Maltepe, Turkey (Türkiye)

View Trial Details

Recruiting

CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma

NCT06850285

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Shanxi Bethune Hospital Taiyuan, Shangxi, China

View Trial Details

Recruiting

Cost-utility Analysis of Ambulatory Dose Escalation of Bispecific Antibodies in Multiple Myeloma.

NCT06846905

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: CHU de Toulouse Toulouse, France

View Trial Details

Recruiting

BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease

NCT04271644

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: 920th Hospital of Joint Logistics Support Force Kunming, Yunnan, China

View Trial Details

Recruiting

Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection

NCT05127980

Conditions: Autoimmune Diseases, Chronic Disease, Connective Tissue Diseases, +27 more
Locations: University Hospital Basel, Division of Internal Medicine Basel, Switzerland

View Trial Details

Recruiting

a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease

NCT04776330

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: 920th Hospital of Joint Logistics Support Force Kunming, Yunnan, China

View Trial Details

Recruiting

PTCy and ATG for MSD and MUD Transplants

NCT06299462

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +20 more
Locations: Instituto Nacional de Cancer Rio de Janeiro, Brazil

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions